Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00833404 · ClinicalTrials.gov registry record · Phase 1
Smoking Cessation and Sexual Health in Men
A Phase 1 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT00833404: Completed Phase 1 study, sponsored by University of Texas at Austin.
NCT00833404 is a Phase 1 study that has completed, run by University of Texas at Austin. The registered enrollment target is 80 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00833404, a Phase 1 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a 12-week clinical trial investigating the effects of smoking cessation on sexual functioning in men. This study consists of 3 sessions and provides 8 weeks of free nicotine transdermal patches. It is hypothesized that men who quit smoking, compared to men who smoke as usual, will demonstrate improved sexual functioning, measured both physiologically (erectile functioning) and subjectively (self-reported sexual functioning).
Interventions
- DRUG Nicotine transdermal patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
What the finished NCT00833404 record still lists
NCT00833404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 1 intervention - of which Nicotine transdermal patch is the first listed.
NCT00833404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00833404 about?
NCT00833404 is a clinical study titled "Smoking Cessation and Sexual Health in Men". This is a 12-week clinical trial investigating the effects of smoking cessation on sexual functioning in men. This study consists of 3 sessions and provides 8 weeks of free nicotine transdermal patches. It is hypothesized that men who quit smoking, compared to men who smoke as usual, will demonstrat...
What is the current status of trial NCT00833404?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2008-12. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00833404?
The interventions under investigation include: Nicotine transdermal patch (DRUG).
Who is sponsoring clinical trial NCT00833404?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00833404's enrollment target sits among peer trials
80 672nd of 2000 higher than 1,305 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia